# Mercer International Inc.: financial statements, quarterly

MERC · Nasdaq · CIK 1333274 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/merc.md) · [Financials](/companies/merc/financials.md) · [Filings](/companies/merc/filings.md) · [Insiders](/companies/merc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/merc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [471](/filings/0000950170-24-119586.md) | [470 d](/filings/0001193125-26-048855.md) | [553](/filings/0000950170-25-061956.md) | [499](/filings/0000950170-25-100958.md) | [502](/filings/0001193125-25-269753.md) | [488 d](/filings/0001193125-26-048855.md) | [507](/filings/0001193125-26-212136.md) | [454](/filings/0001193125-26-338272.md) | [458](/filings/0001193125-25-269753.md) | [450 d](/filings/0001193125-26-048855.md) | [489](/filings/0001193125-26-212136.md) | [460](/filings/0001193125-26-338272.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [30.1](/filings/0000950170-24-119586.md) | [26.7 d](/filings/0001193125-26-048855.md) | [31.7](/filings/0000950170-25-061956.md) | [29.8](/filings/0000950170-25-100958.md) | [29.2](/filings/0001193125-25-269753.md) | [25.8 d](/filings/0001193125-26-048855.md) | [29.7](/filings/0001193125-26-212136.md) | [30.4](/filings/0001193125-26-338272.md) | [28.8](/filings/0001193125-25-269753.md) | [25.5 d](/filings/0001193125-26-048855.md) | [28.5](/filings/0001193125-26-212136.md) | [31.6](/filings/0001193125-26-338272.md) |
| Operating income | $m | [(3.4)](/filings/0000950170-24-119586.md) | [(56.4) d](/filings/0001193125-26-048855.md) | [(0.4)](/filings/0000950170-25-061956.md) | [(43.8)](/filings/0000950170-25-100958.md) | [8.8](/filings/0001193125-25-269753.md) | [50.4 d](/filings/0001193125-26-048855.md) | [6.7](/filings/0001193125-26-212136.md) | [(58.4)](/filings/0001193125-26-338272.md) | [(67.6)](/filings/0001193125-25-269753.md) | [(278) d](/filings/0001193125-26-048855.md) | [(32.9)](/filings/0001193125-26-212136.md) | [(59.0)](/filings/0001193125-26-338272.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.0](/filings/0000950170-24-119586.md) | [1.1 d](/filings/0001193125-26-048855.md) | [(6.4)](/filings/0000950170-25-061956.md) | [1.3](/filings/0000950170-25-100958.md) | [(0.1)](/filings/0001193125-25-269753.md) | [3.4 d](/filings/0001193125-26-048855.md) | [0.7](/filings/0001193125-26-212136.md) | [(1.9)](/filings/0001193125-26-338272.md) | [(14.8)](/filings/0001193125-25-269753.md) | [2.6 d](/filings/0001193125-26-048855.md) | [(8.2)](/filings/0001193125-26-212136.md) | [(13.4)](/filings/0001193125-26-338272.md) |
| Net income | $m | [(26.0)](/filings/0000950170-24-119586.md) | [(87.2) d](/filings/0001193125-26-048855.md) | [(16.7)](/filings/0000950170-25-061956.md) | [(67.6)](/filings/0000950170-25-100958.md) | [(17.6)](/filings/0001193125-25-269753.md) | [16.7 d](/filings/0001193125-26-048855.md) | [(22.3)](/filings/0001193125-26-212136.md) | [(86.1)](/filings/0001193125-26-338272.md) | [(80.8)](/filings/0001193125-25-269753.md) | [(309) d](/filings/0001193125-26-048855.md) | [(52.0)](/filings/0001193125-26-212136.md) | [(76.0)](/filings/0001193125-26-338272.md) |
| Diluted EPS | $ per share | [(0.39)](/filings/0000950170-24-119586.md) | not reported | [(0.25)](/filings/0000950170-25-061956.md) | [(1.01)](/filings/0000950170-25-100958.md) | [(0.26)](/filings/0001193125-25-269753.md) | not reported | [(0.33)](/filings/0001193125-26-212136.md) | [(1.29)](/filings/0001193125-26-338272.md) | [(1.21)](/filings/0001193125-25-269753.md) | not reported | [(0.78)](/filings/0001193125-26-212136.md) | [(1.13)](/filings/0001193125-26-338272.md) |
| Basic EPS | $ per share | [(0.39)](/filings/0000950170-24-119586.md) | not reported | [(0.25)](/filings/0000950170-25-061956.md) | [(1.01)](/filings/0000950170-25-100958.md) | [(0.26)](/filings/0001193125-25-269753.md) | not reported | [(0.33)](/filings/0001193125-26-212136.md) | [(1.29)](/filings/0001193125-26-338272.md) | [(1.21)](/filings/0001193125-25-269753.md) | not reported | [(0.78)](/filings/0001193125-26-212136.md) | [(1.13)](/filings/0001193125-26-338272.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [344](/filings/0000950170-23-058288.md) | [314](/filings/0000950170-25-024217.md) | [274](/filings/0000950170-24-057125.md) | [263](/filings/0000950170-24-094099.md) | [239](/filings/0000950170-24-119586.md) | [185](/filings/0001193125-26-048855.md) | [181](/filings/0000950170-25-061956.md) | [146](/filings/0000950170-25-100958.md) | [98.1](/filings/0001193125-25-269753.md) | [187](/filings/0001193125-26-338272.md) | [84.5](/filings/0001193125-26-212136.md) | [78.8](/filings/0001193125-26-338272.md) |
| Current assets | $m | [1,065](/filings/0000950170-23-058288.md) | [1,093](/filings/0000950170-25-024217.md) | [1,127](/filings/0000950170-24-057125.md) | [1,069](/filings/0000950170-24-094099.md) | [1,059](/filings/0000950170-24-119586.md) | [910](/filings/0001193125-26-048855.md) | [970](/filings/0000950170-25-061956.md) | [938](/filings/0000950170-25-100958.md) | [868](/filings/0001193125-25-269753.md) | [866](/filings/0001193125-26-338272.md) | [835](/filings/0001193125-26-212136.md) | [783](/filings/0001193125-26-338272.md) |
| Total assets | $m | [2,655](/filings/0000950170-23-058288.md) | [2,663](/filings/0000950170-25-024217.md) | [2,605](/filings/0000950170-24-057125.md) | [2,484](/filings/0000950170-24-094099.md) | [2,503](/filings/0000950170-24-119586.md) | [2,263](/filings/0001193125-26-048855.md) | [2,336](/filings/0000950170-25-061956.md) | [2,378](/filings/0000950170-25-100958.md) | [2,291](/filings/0001193125-25-269753.md) | [2,041](/filings/0001193125-26-338272.md) | [1,964](/filings/0001193125-26-212136.md) | [1,870](/filings/0001193125-26-338272.md) |
| Current liabilities | $m | [268](/filings/0000950170-23-058288.md) | [286](/filings/0000950170-25-024217.md) | [302](/filings/0000950170-24-057125.md) | [309](/filings/0000950170-24-094099.md) | [279](/filings/0000950170-24-119586.md) | [257](/filings/0001193125-26-048855.md) | [298](/filings/0000950170-25-061956.md) | [302](/filings/0000950170-25-100958.md) | [288](/filings/0001193125-25-269753.md) | [284](/filings/0001193125-26-338272.md) | [385](/filings/0001193125-26-212136.md) | [601](/filings/0001193125-26-338272.md) |
| Total liabilities | $m | [1,990](/filings/0000950170-23-058288.md) | [2,027](/filings/0000950170-25-024217.md) | [2,032](/filings/0000950170-24-057125.md) | [1,997](/filings/0000950170-24-094099.md) | [1,986](/filings/0000950170-24-119586.md) | [1,833](/filings/0001193125-26-048855.md) | [1,899](/filings/0000950170-25-061956.md) | [1,932](/filings/0000950170-25-100958.md) | [1,931](/filings/0001193125-25-269753.md) | [1,973](/filings/0001193125-26-338272.md) | [1,969](/filings/0001193125-26-212136.md) | [1,968](/filings/0001193125-26-338272.md) |
| Long-term debt | $m | [1,590](/filings/0000950170-23-058288.md) | [1,609](/filings/0000950170-25-024217.md) | [1,615](/filings/0000950170-24-057125.md) | [1,569](/filings/0000950170-24-094099.md) | [1,598](/filings/0000950170-24-119586.md) | [1,474](/filings/0001193125-26-048855.md) | [1,503](/filings/0000950170-25-061956.md) | [1,527](/filings/0000950170-25-100958.md) | [1,547](/filings/0001193125-25-269753.md) | [1,605](/filings/0001193125-26-338272.md) | [1,510](/filings/0001193125-26-212136.md) | [1,306](/filings/0001193125-26-338272.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [13.7](/filings/0001193125-26-338272.md) | [108](/filings/0001193125-26-212136.md) | [330](/filings/0001193125-26-338272.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-212136.md) | [94.3](/filings/0001193125-26-212136.md) | not reported |
| Shareholders' equity | $m | [665](/filings/0000950170-24-119586.md) | [635](/filings/0001193125-26-048855.md) | [574](/filings/0000950170-25-100958.md) | [488](/filings/0001193125-25-269753.md) | [517](/filings/0001193125-25-269753.md) | [430](/filings/0001193125-26-338272.md) | [437](/filings/0001193125-26-338272.md) | [446](/filings/0001193125-26-338272.md) | [360](/filings/0001193125-25-269753.md) | [68.1](/filings/0001193125-26-338272.md) | [(5.5)](/filings/0001193125-26-338272.md) | [(98.0)](/filings/0001193125-26-338272.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(25.3)](/filings/0000950170-24-119586.md) | [(8.7) d](/filings/0001193125-26-048855.md) | [(29.2)](/filings/0000950170-25-061956.md) | [62.2](/filings/0000950170-25-100958.md) | [(13.9)](/filings/0001193125-25-269753.md) | [71.2 d](/filings/0001193125-26-048855.md) | [(3.0)](/filings/0001193125-26-212136.md) | [(4.5)](/filings/0001193125-26-338272.md) | [(30.1)](/filings/0001193125-25-269753.md) | [46.2 d](/filings/0001193125-26-048855.md) | [(85.7)](/filings/0001193125-26-212136.md) | [(15.1)](/filings/0001193125-26-338272.md) |
| Capital expenditure | $m | [37.4](/filings/0000950170-24-119586.md) | [26.0 d](/filings/0001193125-26-048855.md) | [18.5](/filings/0000950170-25-061956.md) | [17.9](/filings/0000950170-25-100958.md) | [27.3](/filings/0001193125-25-269753.md) | [20.7 d](/filings/0001193125-26-048855.md) | [20.1](/filings/0001193125-26-212136.md) | [24.3](/filings/0001193125-26-338272.md) | [30.0](/filings/0001193125-25-269753.md) | [14.2 d](/filings/0001193125-26-048855.md) | [13.2](/filings/0001193125-26-212136.md) | [12.2](/filings/0001193125-26-338272.md) |
| Dividends paid | $m | [5.0](/filings/0000950170-24-119586.md) | [10.0 d](/filings/0001193125-26-048855.md) | not reported | [5.0](/filings/0000950170-25-100958.md) | [5.0](/filings/0001193125-25-269753.md) | [10.0 d](/filings/0001193125-26-048855.md) | not reported | [5.0](/filings/0001193125-26-338272.md) | [5.0](/filings/0001193125-25-269753.md) | [0.0 d](/filings/0001193125-26-048855.md) | not reported | [0.0](/filings/0001193125-26-338272.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [66.6](/filings/0000950170-23-058288.md) | [66.3](/filings/0000950170-24-057125.md) | [66.4](/filings/0000950170-24-094099.md) | [66.5](/filings/0000950170-24-119586.md) | [66.6](/filings/0000950170-25-061956.md) | [66.8](/filings/0000950170-25-100958.md) | [66.8](/filings/0001193125-25-269753.md) | [66.9](/filings/0001193125-26-212136.md) | [66.9](/filings/0001193125-26-338272.md) | [67.0](/filings/0001193125-25-269753.md) | [67.0](/filings/0001193125-26-212136.md) | [67.0](/filings/0001193125-26-338272.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 67,018,033 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-338272.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.